In vitro and in vivo Evaluation of Folic Acid Modified DOX-Loaded (32)P-nHA Nanoparticles in Prostate Cancer Therapy

BACKGROUND: Prostate cancer (PCa) ranks second in the incidence of all malignancies in male worldwide. The presence of multi-organ metastases and tumor heterogeneity often leads to unsatisfactory outcomes of conventional radiotherapy treatments. This study aimed to develop a novel folate-targeted na...

Descripción completa

Detalles Bibliográficos
Autores principales: Deng, Hao, Wang, Yumei, Zhou, Yue, Zhai, Dongliang, Chen, Jie, Hao, Shilei, Chen, Xiaoliang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10108875/
https://www.ncbi.nlm.nih.gov/pubmed/37077940
http://dx.doi.org/10.2147/IJN.S403887

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10108875/
https://www.ncbi.nlm.nih.gov/pubmed/37077940
http://dx.doi.org/10.2147/IJN.S403887

Ejemplares similares